Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erlinge

Showing results (341-350 of 490) with videos related to

Pageof 49
Sort By:
Resuscitation|September 27, 2016
High-sensitivity troponin-T as a prognostic marker after out-of-hospital cardiac arrest - A targeted temperature management (TTM) trial substudyPatrik Gilje, Sasha Koul, Jakob Hartvig Thomsen, et al.
American Heart Journal|August 30, 2023
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarctionStefan James, David Erlinge, Robert F Storey, et al.
Critical Care Medicine|October 16, 2015
Bradycardia During Targeted Temperature Management: An Early Marker of Lower Mortality and Favorable Neurologic Outcome in Comatose Out-of-Hospital Cardiac Arrest PatientsJakob Hartvig Thomsen, Niklas Nielsen, Christian Hassager, et al.
Vascular Health and Risk Management|November 8, 2019
PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserveInger Haraldsson, Li-Ming Gan, Sara Svedlund, et al.
Plos One|June 5, 2012
A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular eventsOlof Gidlöf, J Gustav Smith, Olle Melander, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Clinical Kidney Journal|March 25, 2024
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney functionBarbara Salzinger, Kristina Lundwall, Marie Evans, et al.
Frontiers in Cardiovascular Medicine|April 1, 2021
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
JACC. Advances|June 18, 2026
Contemporary Data on Sex Differences in Coronary Angiography Findings: A Dual-Nation StudyMikael Zhou, Sacharias von Koch, Kevin Kris Warnakula Olesen, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 49

Showing results (341-350 of 490) with videos related to

Sort By:
Pageof 49
Resuscitation|September 27, 2016
High-sensitivity troponin-T as a prognostic marker after out-of-hospital cardiac arrest - A targeted temperature management (TTM) trial substudyPatrik Gilje, Sasha Koul, Jakob Hartvig Thomsen, et al.
American Heart Journal|August 30, 2023
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarctionStefan James, David Erlinge, Robert F Storey, et al.
Critical Care Medicine|October 16, 2015
Bradycardia During Targeted Temperature Management: An Early Marker of Lower Mortality and Favorable Neurologic Outcome in Comatose Out-of-Hospital Cardiac Arrest PatientsJakob Hartvig Thomsen, Niklas Nielsen, Christian Hassager, et al.
Vascular Health and Risk Management|November 8, 2019
PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserveInger Haraldsson, Li-Ming Gan, Sara Svedlund, et al.
Plos One|June 5, 2012
A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular eventsOlof Gidlöf, J Gustav Smith, Olle Melander, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Clinical Kidney Journal|March 25, 2024
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney functionBarbara Salzinger, Kristina Lundwall, Marie Evans, et al.
Frontiers in Cardiovascular Medicine|April 1, 2021
Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI TrialRobin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, et al.
JACC. Advances|June 18, 2026
Contemporary Data on Sex Differences in Coronary Angiography Findings: A Dual-Nation StudyMikael Zhou, Sacharias von Koch, Kevin Kris Warnakula Olesen, et al.
American Heart Journal|March 29, 2025
HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
Pageof 49